Published：Jun 25, 14:10Last updated：Jun 26, 14:06

Supreme Court Rules in Favor of Bayer in Roundup Cancer Lawsuits

Jun. 25, 2026 14:10

The Supreme Court sided with Roundup's manufacturer, blocking thousands of lawsuits alleging cancer risks. The ruling favors the company by limiting legal challenges. Plaintiffs claimed the product lacked adequate warnings about potential health hazards.

Summarized

21News

14Media

Jun. 26, 2026 13:00

A U.S. Supreme Court ruling in April 2026 could protect Bayer from thousands of lawsuits linking its Roundup herbicide to cancer. Protesters gathered outside the Supreme Court in Washington to oppose the decision.

Jun. 26, 2026 14:06

For Bayer, the Supreme Court's glyphosate ruling is a relief. US attorney R. Brent Wisner, who initiated the billion-dollar lawsuits, plans to continue fighting despite the setback – and sees approaches for this. Published on 2026-06-26.

The U.S. Supreme Court ruled in favor of Bayer, blocking thousands of lawsuits alleging that its Roundup weedkiller causes cancer. The 7-2 decision, announced on June 25-26, 2026, stated the company cannot be held liable for failing to provide cancer warnings on packaging. This pivotal victory halts a wave of litigation against Bayer over glyphosate, though protesters gathered outside the Supreme Court opposing the decision. The ruling could lead to dismissal of tens of thousands of cases, including a 2023 Missouri lawsuit where Monsanto was ordered to pay $1.25 million. Tagesschau.de+5

🏛 Legal Ruling Details

The Supreme Court determined Bayer did not need to include cancer warnings, citing EPA opposition to such labels. Justices Jackson and Gorsuch dissented, arguing for consumer risk disclosure. The case originated from a farmer who developed cancer after prolonged Roundup use. Bayer has paid over $10 billion to settle prior lawsuits, but attorney R. Brent Wisner vows to continue legal challenges despite the ruling. Tagesschau.de+3

📈 Market Impact

Bayer's stock surged over 18% following the decision as investors anticipated reduced liabilities. The company expects remaining lawsuits to be dismissed, marking a turning point after years of controversy. The ruling benefits the Trump administration, which supported Bayer's position. Analysts note the decision may shield Bayer from billions in potential payouts. Süddeutsche Zeitung+2

🌾 Industry Implications

The ruling strengthens Bayer's position in agricultural chemicals, where glyphosate remains widely used. Critics warn it may discourage stricter safety evaluations for similar products. The decision sets a precedent impacting future litigation against pesticide manufacturers, though Bayer maintains glyphosate is safe when used as directed. Radio France Internationale+2

⚖️ Dissenting Views

Justice Jackson's dissent emphasized consumer protection, arguing companies should warn about potential hazards regardless of regulatory stances. Environmental groups and health advocates condemned the ruling, while bipartisan critics highlighted ongoing scientific debates. Protesters demonstrated outside the Supreme Court, reflecting persistent public concern. Tagesschau.de+2

BayerMonsantoSupreme CourtMichael HeussenJustice Kavanaugh